Patrick Strasser 3/17/25 Patrick Strasser 3/17/25

Wholomics @ LSI USA ’25

Wholomics, a pioneering early cancer detection company, is set to showcase its groundbreaking multi‐omics platform at LSI USA ’25. Our innovative, minimally invasive blood test detects multiple cancers at their earliest, most treatable stages by capturing subtle molecular changes, offering unprecedented sensitivity and specificity.

Guest User 7/1/24 Guest User 7/1/24

Wholomics joins MassChallenge Accelerator

Wholomics was accepted to a leading Health Tech Accelerator - MassChallenge where it will progress its early cancer detection technology.

Guest User 6/6/24 Guest User 6/6/24

Wholomics @ ASCO Annual Meeting 2024

Wholomics presented its successful blinded validation study on pancreatic cancer at the ASCO Annual Meeting 2024 in Chicago.

Guest User 4/3/24 Guest User 4/3/24

Wholomics @ Deep Tech Momentum 2024: A New Milestone

Wholomics was selected as one of Europe’s top 100 early-stage Deep Tech startups!

Guest User 1/22/24 Guest User 1/22/24

Wholomics @ ASCO GI Symposium 2024

Wholomics presented its successful pilot study on pancreatic cancer at ASCO GI 2024 in San Francisco.

Guest User 12/13/23 Guest User 12/13/23

Wholomics Named Top Oncology Solution Provider in Europe 2023

Wholomics was selected as Top Oncology Solution Provider In Europe in 2023!

Guest User 11/20/23 Guest User 11/20/23

Wholomics Shines at Web Summit 2023 in Lisbon

Wholomics presented its progress using a novel early cancer detection technology at the Web Summit 2023 in Lissabon.

Guest User 11/15/22 Guest User 11/15/22

Wholomics joins the aws First Inkubator

Wholomics joins First Inkubator Program to progress with novel early cancer detection test.